OKUR vs VLTO · P/E 72, rev $2.0M vs P/E 29, rev $5.50B
OnKure Therapeutics, Inc. (OKUR) versus Veralto Corporation (VLTO) — a side-by-side from cached financials, not a winner call.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Veralto Corporation (VLTO) is a pollution & treatment controls company listed on US.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Latest reported VLTO revenue for 2025-12-31 was $5.50B. Net income was $940.0M. Revenue was up 6.0% from 2024-12-31 to 2025-12-31. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
OKUR currently screens at market cap $76.6M and trailing P/E 71.8. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
Not investment advice. Open the OKUR and VLTO stock pages for the full models.
Not investment advice.